Arabic Arabic English English French French German German

Mass General, AstraZeneca Pilot Digital Health Program for Asthma, Heart Failure

Massachusetts General Hospital to Deploy CarePassport’s Digital Health Platform for Clinical Trials

What You Should Know:

Massachusetts General Hospital (MGH) today announced with AstraZeneca to pilot a new digital health platform focused on heart failure and asthma studies to help improve outcomes for patients with chronic diseases.

– This collaboration is being led by the MGH Center for Innovation in Digital Healthcare (CIDH) and will utilize AstraZeneca’s new AMAZE disease management platform in studies for heart failure and asthma management. These first two studies will pilot AMAZE in a real-world setting with the goals of improving patient engagement, care-team communication and clinical outcomes while reducing healthcare costs.

–   Through remote monitoring, AMAZE identifies at-risk patients and delivers insights to the clinical care team at the point of care to improve the management of complex patient populations. The digital platform, including a patient app and clinician dashboard, is intended to speed up evidence-based clinical practice with the aim of continuously improving the standard of patient care and healthcare efficiency.

– Following the successful conclusion of the heart failure and asthma studies, AstraZeneca and Massachusetts General Hospital plan to expand the use of AMAZE across multiple chronic disease areas, reaching patients throughout the Mass General Brigham system, and beyond.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Al-Qassim: 60,000+ Patients Served by Physiotherapy & Rehabilitation Centers Last Year

Next Post

Public Meeting: Patient-Focused Drug Development for Neuropathic Pain (Part 2 of 3)

Related Posts